Announced Mon, 20 Jul · 18:23 IST
Board meeting on July 24 to consider Q1 FY27 results
Results View source PDF
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹1685.00
prior close
₹1705.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.7-1.9-2.1-2.7-1.3-2.7-2.1+0.1——————
Up moveDown movePending
AI summary
OneSource Specialty Pharma has informed BSE that its Board of Directors will meet on Friday, July 24, 2026 to consider and approve the unaudited financial results, both standalone and consolidated, for the quarter ended June 30, 2026. The trading window for designated persons is already closed from July 1, 2026 and will reopen 48 hours after the results are published. No financial numbers have been shared yet.
Likely market impact
Investors should await the Q1 FY27 results on July 24 for actual performance data; no immediate price catalyst from this intimation.